Brief: Aroa Biosurgery Posts H1 Product Revenue Of NZ$17.2 Million
27/10/2021 02:29
Oct 27 (Reuters) - Aroa Biosurgery Ltd ARX.AX :
* H1 PRODUCT REVENUE NZ$17.2 MILLION
* TOTAL REPORTED H1 REVENUE INCLUSIVE OF PROJECT FEES WAS
NZ$17.9
MILLION
* FY22 GUIDANCE FOR PRODUCT REVENUE ON CONSTANT CURRENCY
BASIS
UPGRADED TO NZ$34-37 MILLION FROM PREVIOUS GUIDANCE OF NZ$30-33
MILLION
Source text for Eikon: ID:nASX5j9lVZ
Further company coverage: ARX.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aroa Biosurgery
See all newsAustralia-listed Aroa Biosurgery climbs as annual earnings beat guidance
Brief: Aroa Biosurgery Posts Adjusted EBITDA Of NZ$12.6 Million
Aroa Biosurgery climbs as prelim annual results beat outlook
Brief: Aroa Biosurgery Posts FY26 Prelim Total Revenue Of NZ$104 Million
Brief: Aroa Biosurgery Says Expects FY26 Revenue At Upper End Of NZ$92-100 Million